Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Palatin Technologies, Inc./ SCHEDULE 13G/A

SEC Filing · SCHEDULE 13G/A

Palatin Technologies, Inc.

PTNNASDAQEQUITYCurrent

SEC Filing

Filed Aug 14, 2026Accepted Aug 14, 2026, 12:16 PM EDTCIK 911216Accession 0002131234-26-000002
View company →Permanent SEC source ↗
Share

Company context

We are a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems. Our product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

Current securities

PTNNASDAQ · EQUITY · Current
Historical securities (3)
PTNNYSE_AMERICAN · EQUITY · Historical · closed May 6, 2025PTNNYSE_AMERICAN · EQUITY · Historical · closed May 27, 2026PTNTOTC · EQUITY · Historical · closed Nov 17, 2025

Recent company filings

  1. 10-K filingSep 28, 2026
  2. Submission of Matters to a Vote of Security HoldersAug 3, 2026
  3. DEF 14A filingJun 25, 2026
  4. CERT filingMay 28, 2026
  5. 8-A12B filingMay 28, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗